Evaluation of the Quality of Bowel Cleansing in a Real Clinical Practice Setting (CALICOL)

January 24, 2018 updated by: Casen Recordati S.L.

Evaluation of the Quality of Bowel Cleansing in a Real Clinical Practice Setting (CALICOL Study)

Publications of the use of bowel cleansers in usual clinical practice are lacking. Patient adherence to investigational products increases in the context of clinical trials. By the same token, efficacy of interventions may be overestimated in clinical trials.

For this reason, an observational study to collect data on the effectiveness of several colonic preparations when these are used under usual clinical practice is proposed.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

412

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Barcelona
      • Esplugues de Llobregat, Barcelona, Spain, 08950
        • Clínica de Medicina Integral Diagonal

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Adult patients who have been performed a colonoscopy and who have received a bowel cleansing agent according to the investigator criteria

Description

Inclusion Criteria:

  • Age 18-80 years
  • Subjects who have been performed a colonoscopy

Exclusion Criteria:

  • Subjects being previously performed colon surgery.
  • Subjects suffering from active inflammatory bowel disease at the time of performing colonoscopy.
  • Subjects with extreme limitations due to disease.
  • Subjects in who Boston Bowel Preparation Scale (BBPS) is not available
  • Subjects who have undergone a colonoscopy during their participation in another clinical study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percentage of patients with adequate colon cleansing
Time Frame: Through study completion, an average of 6 months
Percentage of patients with punctuation in Boston bowel preparation scale (BBPS) ≥ 5
Through study completion, an average of 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percentage of patients with adequate colon cleansing of different administration schedules
Time Frame: Through study completion, an average of 6 months
Percentage of patients with punctuation in BBPS ≥ 5 in each administration schedule
Through study completion, an average of 6 months
Identify factors influencing bowel cleansing quality
Time Frame: Through study completion, an average of 6 months
Relationship between BBPS ≥ 5 and age, gender, ethnicity, weight, height, tobacco consumption, concomitant diseases, medications and indication for colonoscopy in a multivariate analysis.
Through study completion, an average of 6 months
Influence of total volume of liquid ingestion in the effectiveness of bowel cleansing agents
Time Frame: Through study completion, an average of 6 months
Relationship between BBPS ≥ 5and the volume of liquid ingestion
Through study completion, an average of 6 months
Patients' tolerance
Time Frame: Through study completion, an average of 6 months
Percentage of each adverse event reported per patient in each administration schedule
Through study completion, an average of 6 months
Quality of bowel cleansing comparison among different bowel cleansing agents
Time Frame: Through study completion, an average of 6 months
Comparison of percentage of patients with BBPS ≥ 5 between different bowel cleansing agents
Through study completion, an average of 6 months
Subjects' satisfaction
Time Frame: Through study completion, an average of 6 months
Comparison of subjects' satisfaction between different bowel cleansing agents with a five point likert scale
Through study completion, an average of 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Ana Bargalló, MD, Clínica de Medicina Integral Diagonal, Gastroenterology department

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 15, 2016

Primary Completion (Actual)

March 6, 2017

Study Completion (Actual)

March 6, 2017

Study Registration Dates

First Submitted

July 14, 2016

First Submitted That Met QC Criteria

July 18, 2016

First Posted (Estimate)

July 21, 2016

Study Record Updates

Last Update Posted (Actual)

January 26, 2018

Last Update Submitted That Met QC Criteria

January 24, 2018

Last Verified

January 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • CAS-EVA-2016-01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Bowel Preparation for Colonoscopy

Clinical Trials on Bowel preparation

3
Subscribe